Two types of TNF receptors are expressed on human normal and malignant B lymphocytes

Clin Immunol Immunopathol. 1991 Nov;61(2 Pt 1):260-7. doi: 10.1016/s0090-1229(05)80029-7.

Abstract

We analyzed the expression of the 75- and 55-kDa tumor necrosis factor (TNF) receptors on the surface of human normal and malignant B cells. Freshly isolated tonsillar B cells do not express detectable amounts of receptors. After 24 hr of stimulation with anti-IgM and low-molecular-weight (l.m.w.) BCGF, B cells express the 75-kDa receptor but not the 55-kDa receptor, but after 48 hr of stimulation both types of receptors are expressed. Three of 10 patients with B-chronic lymphatic leukemia or hairy cell leukemia (HCL) had a small population of TNF receptor positive tumor cells; after in vitro stimulation of tumor cells in 10/10 patients various patterns of 75- and 55-kDa TNF receptor expression were found. MAb UTR-1, which binds the 75-kDa receptor, inhibits the l.m.w. BCGF-induced [3H]thymidine incorporation of cultured tonsillar B cells and HCL cells. This may provide evidence that in B cells the 75 kDa TNF receptor molecule is functionally active.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / immunology
  • B-Lymphocytes / chemistry*
  • Cell Division
  • Cells, Cultured
  • Humans
  • Leukemia, Hairy Cell / metabolism*
  • Leukemia, Hairy Cell / pathology
  • Leukemia, Lymphocytic, Chronic, B-Cell / metabolism*
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology
  • Lymphocyte Activation
  • Receptors, Cell Surface / analysis*
  • Receptors, Cell Surface / immunology
  • Receptors, Cell Surface / physiology
  • Receptors, Tumor Necrosis Factor

Substances

  • Antibodies, Monoclonal
  • Receptors, Cell Surface
  • Receptors, Tumor Necrosis Factor